Annual EBIT:
$11.56M+$129.55M(+109.80%)Summary
- As of today, BCRX annual earnings before interest & taxes is $11.56 million, with the most recent change of +$129.55 million (+109.80%) on December 31, 2024.
- During the last 3 years, BCRX annual EBIT has risen by +$134.08 million (+109.44%).
- BCRX annual EBIT is now at all-time high.
Performance
BCRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$28.07M+$3.82M(+15.73%)Summary
- As of today, BCRX quarterly earnings before interest & taxes is $28.07 million, with the most recent change of +$3.82 million (+15.73%) on June 30, 2025.
- Over the past year, BCRX quarterly EBIT has increased by +$15.84 million (+129.48%).
- BCRX quarterly EBIT is now at all-time high.
Performance
BCRX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$62.16M+$15.84M(+34.19%)Summary
- As of today, BCRX TTM earnings before interest & taxes is $62.16 million, with the most recent change of +$15.84 million (+34.19%) on June 30, 2025.
- Over the past year, BCRX TTM EBIT has increased by +$107.49 million (+237.13%).
- BCRX TTM EBIT is now at all-time high.
Performance
BCRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BCRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +109.8% | +129.5% | +237.1% |
| 3Y3 Years | +109.4% | +182.6% | +149.5% |
| 5Y5 Years | +111.9% | +178.7% | +155.2% |
BCRX EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +108.0% | at high | +161.5% | at high | +142.8% |
| 5Y | 5-Year | at high | +106.9% | at high | +151.1% | at high | +133.6% |
| All-Time | All-Time | at high | +106.9% | at high | +151.1% | at high | +133.6% |
BCRX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $28.07M(+15.7%) | $62.16M(+34.2%) |
| Mar 2025 | - | $24.25M(+1672.8%) | $46.32M(+300.6%) |
| Dec 2024 | $11.56M(+109.8%) | -$1.54M(-113.5%) | $11.56M(+145.4%) |
| Sep 2024 | - | $11.38M(-6.9%) | -$25.48M(+43.8%) |
| Jun 2024 | - | $12.23M(+216.4%) | -$45.33M(+56.1%) |
| Mar 2024 | - | -$10.51M(+72.8%) | -$103.23M(+12.5%) |
| Dec 2023 | -$117.99M(+18.8%) | -$38.58M(-355.3%) | -$117.99M(+5.2%) |
| Sep 2023 | - | -$8.47M(+81.4%) | -$124.42M(+5.9%) |
| Jun 2023 | - | -$45.67M(-80.8%) | -$132.17M(-9.7%) |
| Mar 2023 | - | -$25.27M(+43.9%) | -$120.48M(+17.1%) |
| Dec 2022 | -$145.29M(-18.6%) | -$45.01M(-177.4%) | -$145.29M(-49.7%) |
| Sep 2022 | - | -$16.22M(+52.3%) | -$97.03M(+22.7%) |
| Jun 2022 | - | -$33.98M(+32.1%) | -$125.49M(-3.5%) |
| Mar 2022 | - | -$50.08M(-1639.0%) | -$121.22M(+1.1%) |
| Dec 2021 | -$122.52M(+27.2%) | $3.25M(+107.3%) | -$122.52M(+32.2%) |
| Sep 2021 | - | -$44.69M(-50.4%) | -$180.65M(-1.0%) |
| Jun 2021 | - | -$29.70M(+42.2%) | -$178.84M(+3.2%) |
| Mar 2021 | - | -$51.38M(+6.4%) | -$184.83M(-10.0%) |
| Dec 2020 | -$168.31M(-73.5%) | -$54.88M(-28.0%) | -$168.00M(-49.1%) |
| Sep 2020 | - | -$42.88M(-20.1%) | -$112.65M(-8.0%) |
| Jun 2020 | - | -$35.69M(-3.3%) | -$104.32M(-1.1%) |
| Mar 2020 | - | -$34.55M(-7530.5%) | -$103.23M(-6.4%) |
| Dec 2019 | -$97.00M(-5.4%) | $465.00K(+101.3%) | -$97.00M(+20.8%) |
| Sep 2019 | - | -$34.55M(+0.1%) | -$122.49M(-6.3%) |
| Jun 2019 | - | -$34.59M(-22.1%) | -$115.19M(-18.9%) |
| Mar 2019 | - | -$28.33M(-13.2%) | -$96.85M(-5.2%) |
| Dec 2018 | -$92.08M(-60.9%) | -$25.02M(+8.2%) | -$92.08M(-9.1%) |
| Sep 2018 | - | -$27.25M(-67.7%) | -$84.37M(-20.3%) |
| Jun 2018 | - | -$16.25M(+31.0%) | -$70.11M(-2.1%) |
| Mar 2018 | - | -$23.56M(-36.1%) | -$68.65M(-20.0%) |
| Dec 2017 | -$57.22M(-17.6%) | -$17.31M(-33.2%) | -$57.22M(-35.3%) |
| Sep 2017 | - | -$12.99M(+12.2%) | -$42.28M(-7.4%) |
| Jun 2017 | - | -$14.79M(-22.1%) | -$39.35M(+0.2%) |
| Mar 2017 | - | -$12.12M(-410.9%) | -$39.41M(+19.0%) |
| Dec 2016 | -$48.66M(-28.7%) | -$2.37M(+76.4%) | -$48.66M(+22.9%) |
| Sep 2016 | - | -$10.06M(+32.3%) | -$63.08M(+5.0%) |
| Jun 2016 | - | -$14.86M(+30.4%) | -$66.40M(-46.5%) |
| Mar 2016 | - | -$21.36M(-27.2%) | -$45.33M(-19.9%) |
| Dec 2015 | -$37.82M(+5.9%) | -$16.80M(-25.5%) | -$37.82M(-20.5%) |
| Sep 2015 | - | -$13.38M(-315.6%) | -$31.38M(-23.0%) |
| Jun 2015 | - | $6.21M(+144.8%) | -$25.51M(+43.5%) |
| Mar 2015 | - | -$13.85M(-33.7%) | -$45.15M(-12.3%) |
| Dec 2014 | -$40.19M(-58.7%) | -$10.36M(-37.8%) | -$40.19M(-18.1%) |
| Sep 2014 | - | -$7.51M(+44.0%) | -$34.02M(-2.1%) |
| Jun 2014 | - | -$13.42M(-50.9%) | -$33.32M(-7.8%) |
| Mar 2014 | - | -$8.89M(-112.4%) | -$30.90M(-22.0%) |
| Dec 2013 | -$25.33M(+26.4%) | -$4.19M(+38.5%) | -$25.33M(+18.3%) |
| Sep 2013 | - | -$6.81M(+38.1%) | -$31.02M(+5.3%) |
| Jun 2013 | - | -$11.01M(-230.9%) | -$32.74M(+0.3%) |
| Mar 2013 | - | -$3.33M(+66.3%) | -$32.85M(+4.6%) |
| Dec 2012 | -$34.41M(+35.3%) | -$9.87M(-15.7%) | -$34.41M(+12.1%) |
| Sep 2012 | - | -$8.53M(+23.2%) | -$39.17M(+9.8%) |
| Jun 2012 | - | -$11.12M(-127.2%) | -$43.44M(+6.7%) |
| Mar 2012 | - | -$4.89M(+66.6%) | -$46.57M(+12.4%) |
| Dec 2011 | -$53.17M(-57.1%) | -$14.63M(-14.2%) | -$53.18M(-10.0%) |
| Sep 2011 | - | -$12.80M(+10.1%) | -$48.35M(-3.9%) |
| Jun 2011 | - | -$14.24M(-23.9%) | -$46.54M(-9.2%) |
| Mar 2011 | - | -$11.50M(-17.3%) | -$42.62M(-25.9%) |
| Dec 2010 | -$33.85M(-146.4%) | -$9.80M(+10.8%) | -$33.85M(-277.7%) |
| Sep 2010 | - | -$10.99M(-6.4%) | -$8.96M(-3.4%) |
| Jun 2010 | - | -$10.33M(-278.5%) | -$8.67M(-22.5%) |
| Mar 2010 | - | -$2.73M(-118.1%) | -$7.08M(+48.5%) |
| Dec 2009 | -$13.74M | $15.09M(+241.0%) | -$13.74M(+27.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$10.70M(-22.4%) | -$19.02M(-6.3%) |
| Jun 2009 | - | -$8.74M(+6.9%) | -$17.89M(+20.6%) |
| Mar 2009 | - | -$9.39M(-195.7%) | -$22.54M(+17.0%) |
| Dec 2008 | -$27.16M(+15.8%) | $9.80M(+202.4%) | -$27.16M(+32.8%) |
| Sep 2008 | - | -$9.57M(+28.5%) | -$40.40M(+5.4%) |
| Jun 2008 | - | -$13.38M(+4.5%) | -$42.69M(-15.7%) |
| Mar 2008 | - | -$14.02M(-308.9%) | -$36.89M(-54.9%) |
| Dec 2007 | -$32.28M(+31.3%) | -$3.43M(+71.1%) | -$23.81M(+23.5%) |
| Sep 2007 | - | -$11.86M(-56.4%) | -$31.12M(+12.9%) |
| Jun 2007 | - | -$7.58M(-705.9%) | -$35.72M(+8.8%) |
| Mar 2007 | - | -$940.80K(+91.2%) | -$39.15M(+16.7%) |
| Dec 2006 | -$46.98M(-72.9%) | -$10.74M(+34.8%) | -$46.98M(-7.4%) |
| Sep 2006 | - | -$16.46M(-49.4%) | -$43.73M(-24.2%) |
| Jun 2006 | - | -$11.02M(-25.7%) | -$35.20M(-16.9%) |
| Mar 2006 | - | -$8.77M(-17.1%) | -$30.11M(-10.8%) |
| Dec 2005 | -$27.18M(-24.9%) | -$7.49M(+5.5%) | -$27.18M(-8.2%) |
| Sep 2005 | - | -$7.93M(-33.6%) | -$25.12M(-10.9%) |
| Jun 2005 | - | -$5.93M(-1.7%) | -$22.64M(-3.2%) |
| Mar 2005 | - | -$5.83M(-7.4%) | -$21.94M(-0.9%) |
| Dec 2004 | -$21.75M(-59.0%) | -$5.43M(+0.4%) | -$21.75M(-5.8%) |
| Sep 2004 | - | -$5.45M(-4.2%) | -$20.55M(-11.0%) |
| Jun 2004 | - | -$5.23M(+7.3%) | -$18.51M(-12.0%) |
| Mar 2004 | - | -$5.64M(-33.4%) | -$16.53M(-20.9%) |
| Dec 2003 | -$13.68M(+26.9%) | -$4.23M(-24.1%) | -$13.68M(+4.6%) |
| Sep 2003 | - | -$3.41M(-4.8%) | -$14.33M(+0.0%) |
| Jun 2003 | - | -$3.25M(-16.6%) | -$14.34M(+12.2%) |
| Mar 2003 | - | -$2.79M(+42.9%) | -$16.34M(+14.8%) |
| Dec 2002 | -$18.70M(-275.2%) | -$4.88M(-43.0%) | -$19.16M(-13.5%) |
| Sep 2002 | - | -$3.42M(+34.9%) | -$16.88M(-24.3%) |
| Jun 2002 | - | -$5.25M(+6.6%) | -$13.59M(-64.0%) |
| Mar 2002 | - | -$5.62M(-115.6%) | -$8.28M(-58.3%) |
| Dec 2001 | -$4.99M(+49.3%) | -$2.60M(-2088.7%) | -$5.23M(+7.9%) |
| Sep 2001 | - | -$119.00K(-316.4%) | -$5.68M(+24.7%) |
| Jun 2001 | - | $55.00K(+102.1%) | -$7.55M(+24.8%) |
| Mar 2001 | - | -$2.57M(+16.0%) | -$10.04M(-1.6%) |
| Dec 2000 | -$9.83M(-21.4%) | -$3.06M(-54.0%) | -$9.88M(-7.1%) |
| Sep 2000 | - | -$1.98M(+18.5%) | -$9.23M(+6.2%) |
| Jun 2000 | - | -$2.43M(-0.9%) | -$9.85M(-24.3%) |
| Mar 2000 | - | -$2.41M(-0.5%) | -$7.92M(+1.1%) |
| Dec 1999 | -$8.10M(-35.0%) | -$2.40M(+7.7%) | -$8.01M(-8.1%) |
| Sep 1999 | - | -$2.60M(-411.6%) | -$7.41M(-207.6%) |
| Jun 1999 | - | -$508.00K(+79.7%) | -$2.41M(+52.8%) |
| Mar 1999 | - | -$2.50M(-38.9%) | -$5.10M(+12.1%) |
| Dec 1998 | -$6.00M(+51.2%) | -$1.80M(-175.0%) | -$5.80M(+21.6%) |
| Sep 1998 | - | $2.40M(+175.0%) | -$7.40M(+41.3%) |
| Jun 1998 | - | -$3.20M(0.0%) | -$12.60M(-5.9%) |
| Mar 1998 | - | -$3.20M(+5.9%) | -$11.90M(+2.5%) |
| Dec 1997 | -$12.30M(-41.4%) | -$3.40M(-21.4%) | -$12.20M(-1.7%) |
| Sep 1997 | - | -$2.80M(-12.0%) | -$12.00M(-3.4%) |
| Jun 1997 | - | -$2.50M(+28.6%) | -$11.60M(-11.5%) |
| Mar 1997 | - | -$3.50M(-9.4%) | -$10.40M(-18.2%) |
| Dec 1996 | -$8.70M(+4.4%) | -$3.20M(-33.3%) | -$8.80M(-11.4%) |
| Sep 1996 | - | -$2.40M(-84.6%) | -$7.90M(-3.9%) |
| Jun 1996 | - | -$1.30M(+31.6%) | -$7.60M(+5.0%) |
| Mar 1996 | - | -$1.90M(+17.4%) | -$8.00M(+11.1%) |
| Dec 1995 | -$9.10M(-33.8%) | -$2.30M(-9.5%) | -$9.00M(-4.7%) |
| Sep 1995 | - | -$2.10M(-23.5%) | -$8.60M(-4.9%) |
| Jun 1995 | - | -$1.70M(+41.4%) | -$8.20M(+2.4%) |
| Mar 1995 | - | -$2.90M(-52.6%) | -$8.40M(-20.0%) |
| Dec 1994 | -$6.80M | -$1.90M(-11.8%) | -$7.00M(-37.3%) |
| Sep 1994 | - | -$1.70M(+10.5%) | -$5.10M(-50.0%) |
| Jun 1994 | - | -$1.90M(-26.7%) | -$3.40M(-126.7%) |
| Mar 1994 | - | -$1.50M | -$1.50M |
FAQ
- What is BioCryst Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is BioCryst Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of BCRX is $11.56M
What is the all-time high annual EBIT for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is $11.56M
What is BioCryst Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, BCRX annual earnings before interest & taxes has changed by +$129.55M (+109.80%)
What is BioCryst Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of BCRX is $28.07M
What is the all-time high quarterly EBIT for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $28.07M
What is BioCryst Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, BCRX quarterly earnings before interest & taxes has changed by +$15.84M (+129.48%)
What is BioCryst Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of BCRX is $62.16M
What is the all-time high TTM EBIT for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is $62.16M
What is BioCryst Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, BCRX TTM earnings before interest & taxes has changed by +$107.49M (+237.13%)